We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Impact of proton radiotherapy on treatment timing in pediatric and adult patients with CNS tumors.
- Authors
Jin, Michael C; Shi, Siyu; Wu, Adela; Sandhu, Navjot; Xiang, Michael; Soltys, Scott G; Hiniker, Susan; Li, Gordon; Pollom, Erqi L
- Abstract
Background Despite putative benefits associated with proton radiotherapy in the setting of CNS tumors, numerous barriers limit treatment accessibility. Given these challenges, we explored the association of proton use with variations in treatment timing. Methods Pediatric and adult patients with histologically confirmed CNS tumors were identified from the National Cancer Database (2004-2015). Univariable and multivariable regression models were constructed to assess factors impacting radiation timing. Multivariable Cox regression was used to evaluate the effect of treatment delay on survival. Results A total of 76 157 patients received photon or proton radiotherapy. Compared to photons, time to proton administration was longer in multiple pediatric (embryonal, ependymal, nonependymal glial, and other) and adult (ependymal, nonependymal glial, meningeal, other) tumor histologies. On adjusted analysis, proton radiotherapy was associated with longer delays in radiotherapy administration in pediatric embryonal tumors (+3.00 weeks, P =.024) and in all adult tumors (embryonal [+1.36 weeks, P =.018], ependymal [+3.15 weeks, P <.001], germ cell [+2.65 weeks, P =.024], glial [+2.15 weeks, P <.001], meningeal [+5.05 weeks, P <.001], and other [+3.06 weeks, P <.001]). In patients with high-risk tumors receiving protons, delays in adjuvant radiotherapy were independently associated with poorer survival (continuous [weeks], adjusted hazard ratio = 1.09, 95% CI = 1.02-1.16). Conclusions Proton radiotherapy is associated with later radiation initiation in pediatric and adult patients with CNS tumors. In patients with high-risk CNS malignancies receiving protons, delayed adjuvant radiotherapy is associated with poorer survival. Further studies are needed to understand this discrepancy to maximize the potential of proton radiotherapy for CNS malignancies.
- Subjects
CHILD patients; CENTRAL nervous system tumors; PEDIATRIC therapy; PROTONS; TREATMENT effectiveness; TREATMENT delay (Medicine)
- Publication
Neuro-Oncology Practice, 2020, Vol 7, Issue 6, p626
- ISSN
2054-2577
- Publication type
Article
- DOI
10.1093/nop/npaa034